Year Founded
2012
Ownership
Private
Employees
~50
Therapeutic Areas
Rare DiseasesNeurology
Stage
Commercial
Modalities
Small molecule

Aucta Pharmaceuticals General Information

Commercial stage pharmaceutical company focused on 505(b)(2) pathway development of improved formulations of existing drugs. Has successfully launched multiple products including deferasirox granules and lacosamide extended-release capsules.

Contact Information

Website
Primary Industry
Pharma
Corporate Office
Piscataway, New Jersey
United States

Drug Pipeline

deferasirox
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Aucta Pharmaceuticals's pipeline data

Book a demo

Key Partnerships

Oakrum Pharma

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Aucta Pharmaceuticals Funding

Deal TypeDateAmountStatusStage
Later Stage VCNov 4, 2021$15.6MCompletedCommercial
Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Aucta Pharmaceuticals's complete valuation and funding history, request access »